South Texas Accelerated Research Therapeutics, or START, and BGI Tech kicked off a project last week that aims to sequence at least 1,000 and potentially up to 10,000 cancer genomes from patients at primary diagnosis and correlate the genomic alterations with extensive clinical outcome data about the patients' drug regimen and disease progression.

The goal of the project is to aid cancer drug development by identifying both new targets as well as gaining a better understanding of response and resistance to existing drugs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.